IL11 and neoplasm: Since gp130F/F tumour development has been shown to be driven by IL-11 upregulation, [35, 36] attenuated Il11 expression and tumour growth seen in the compound mutant mice suggests that IL-33 might play a key role in the persistence of inflammation that leads to tumorigenesis.